Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 01:47:02 2024-04-23 pm EDT			5-day change	1st Jan Change
72.86 ^USD	+1.14%		+2.20%	-3.86%

Apr. 12	Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating	MT
Apr. 12	Constellation Brands, Inc: Cash machine

Henry Schein, Inc. Provides Earnings Guidance for the Year 2023

May 09, 2023 at 10:00 am EDT

Henry Schein, Inc. provided earnings guidance for the year 2023. The company's guidance for 2023 assumes total sales growth of approximately 1% to 3% over 2022. The company's sales growth guidance reflects 1 less selling week in 2023 than in 2022.

Latest news about Henry Schein, Inc.

Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating	Apr. 12	MT
Constellation Brands, Inc: Cash machine	Apr. 12
Henry Schein, Inc. Announces Appointment of Members to the Company?S Executive Management Committee	Apr. 10	CI
Henry Schein Closes Acquisition of Majority Stake in TriMed	Apr. 04	MT
Henry Schein, Inc. completed the acquisition of an unknown majority interest in TriMed, Inc.	Apr. 03	CI
Viome Is Partnering with Henry Schein, Inc. to Provide Better Access to Oral Health Pro with Cancerdetect	Apr. 02	CI
Henry Schein Insider Sold Shares Worth $477,620, According to a Recent SEC Filing	Mar. 21	MT
JPMorgan Adjusts Henry Schein's Price Target to $88 From $82, Reiterates Overweight Rating	Mar. 06	MT
Jefferies Adjusts Henry Schein's Price Target to $81 From $74, Maintains Hold Rating	Mar. 06	MT
Barrington Boosts Price Target on Henry Schein to $90 From $82, Keeps Outperform Rating	Feb. 28	MT
Transcript : Henry Schein, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Henry Schein forecasts 2024 profit below estimates as cyber attack impact weighs	Feb. 27	RE
Stocks Rise Pre-Bell as Investors Digest Latest Corporate Earnings; Asia Up, Europe Mixed	Feb. 27	MT
Henry Schein Q4 Adjusted Earnings, Net Sales Fall; Sets 2024 Guidance	Feb. 27	MT
North American Morning Briefing : Stock Futures -2-	Feb. 27	DJ
Tranche Update on Henry Schein, Inc.'s Equity Buyback Plan announced on December 13, 2018.	Feb. 27	CI
Earnings Flash (HSIC) HENRY SCHEIN Posts Q4 Revenue $3.02B, vs. Street Est of $3.04B	Feb. 27	MT
Earnings Flash (HSIC) HENRY SCHEIN Reports Q4 EPS $0.66, vs. Street Est of $0.70	Feb. 27	MT
MORNING BID AMERICAS-Anxious bonds catch a bid as Mideast eyed	Feb. 27	RE
Henry Schein, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 30, 2023	Feb. 27	CI
Leerink Partners Initiates Henry Schein at Market Perform Rating With $78 Price Target	Feb. 26	MT
Piper Sander Raises Henry Schein Price Target to $86 From $78, Maintains Overweight Rating	Feb. 26	MT
Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting	Feb. 19	CI
Lumos Diagnostics Hires Henry Schein as US Distributor for Respiratory Infection Blood Test; Shares Rise 4%	Feb. 11	MT
UBS Adjusts Henry Schein Price Target to $78 From $75, Maintains Neutral Rating	Feb. 08	MT

Chart Henry Schein, Inc.

Duration

Period

More charts

Company Profile

Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows: - distribution of health care products and equipment (94.3%): dental products and equipment (62.7% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (37.3%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.); - other (5.7%): sale and integration of management software, financial, training, maintenance and equipment repair services. The United States account for 76.2% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Henry Schein, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

72.04 USD

Average target price

80.63 USD

Spread / Average Target

+11.92%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

	1st Jan change	Capi.
HENRY SCHEIN, INC.	-3.86%	9.26B
OWENS & MINOR, INC.	+32.02%	1.86B
SHIP HEALTHCARE HOLDINGS, INC.	-6.06%	1.36B
AS ONE CORPORATION	-8.02%	1.18B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-20.64%	815M
TOKAI CORP.	0.00%	479M
EXCELSIOR MEDICAL CO., LTD.	+4.75%	431M
GAUSH MEDITECH LTD	-51.75%	332M
COWEALTH MEDICAL CHINA CO.,LTD.	-26.96%	318M
WIN-PARTNERS CO., LTD.	-2.09%	218M

Medical Equipment Wholesale